Related Experiment Video
Updated: Jun 24, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Pharmacy education and practice in 13 Middle Eastern countries.
Nadir Kheir1, Manal Zaidan, Husam Younes
1College of Pharmacy, Qatar University, Doha, Qatar.
American Journal of Pharmaceutical Education
|March 28, 2009
Summary
Pharmacy education in the Middle East is rapidly evolving, with 78 schools identified across 12 countries. However, pharmacy practice advancement, especially in the private sector, lags behind educational reforms.
Area of Science:
- Pharmacy
- Middle Eastern Health Systems
Background:
- The Arab world has a long history of contributions to pharmacy.
- Pharmacy education and practice in Middle Eastern Arabic-speaking countries are evolving.
- Limited English literature exists on this region's pharmacy landscape.
Purpose of the Study:
- To provide a high-level overview of pharmacy education and practice in the Middle East.
- To identify key statistics and trends in the region's pharmacy sector.
Main Methods:
- Review of published literature.
- Analysis of university and program websites.
- Direct contact with program and country representatives.
- Inclusion of 13 countries in the review.
Main Results:
- Seventy-eight active pharmacy schools identified in 12 countries.
- Over 14,000 students annually admitted to baccalaureate programs, with 75% from Egypt.
- The 5-year baccalaureate degree is the standard entry-level professional degree.
- Pharmacy education has advanced rapidly; practice, especially in the private sector, is advancing more slowly.
- Hospital pharmacists generally have advanced degrees and higher practice levels than community pharmacists.
Conclusions:
- Significant advancements in pharmacy education are occurring in the Middle East.
- There is a disparity between the pace of educational reform and practice development.
- Hospital pharmacy practice is more advanced than community pharmacy practice.
- Despite challenges, a strong commitment exists to enhance pharmacy science and practice in the region.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:06Three-Compartment Open Model
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...